PROCEPT BioRobotics Corp PRCT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
PROCEPT BioRobotics (NASDAQ: PRCT) Investors: Securities Class Action Filed; Shareholders Should Contact Shareholders Foundation
-
PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT
-
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit
-
PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
-
PRCT FINAL DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit
-
PROCEPT 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT
-
PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline
-
SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2026 - PRCT
Trading Information
- Previous Close Price
- $18.40
- Day Range
- $18.46–19.80
- 52-Week Range
- $16.67–38.11
- Bid/Ask
- $19.03 / $20.00
- Shares Outstanding
- 57.27M
- Market Cap
- $1.12B
- Volume/Avg
- 2M / 1M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.27
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 888
Valuation
|
Metric
|
PRCT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.30 |
Price/Sales | 3.27 |
Price/Cash Flow | — |
Price/Earnings
PRCT
Financial Strength
|
Metric
|
PRCT
|
|---|---|
Quick Ratio | 5.23 |
Current Ratio | 6.55 |
Interest Coverage | −32.94 |
Quick Ratio
PRCT
Profitability
|
Metric
|
PRCT
|
|---|---|
Return on Assets (Normalized) | −11.02% |
Return on Equity (Normalized) | −15.14% |
Return on Invested Capital (Normalized) | −13.56% |
Return on Assets
PRCT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|K<%%&M | LOCK|f&m&% | $176B | |||
| Medtronic PLC
MDT
| LOCK|psf##VK | LOCK|srQP$ | $118B | |||
| Stryker Corp
SYK
| LOCK|?zPR&&&S | LOCK|t! | $108B | |||
| Boston Scientific Corp
BSX
| LOCK|km<X>H | LOCK|bGNl | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|cK%w$Yf^ | LOCK|hcy#L | $50B | |||
| DexCom Inc
DXCM
| LOCK|$^>wJ%?! | LOCK|?XQNS | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|@?kCWm | LOCK|@^& | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|nl | LOCK|?& | $24B | |||
| Steris PLC
STE
| LOCK|k%&qh^# | LOCK|vGf#? | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|L^#dR&G | LOCK|&F | $18B |
United States